Targeted Medical Pharma Inc (TRGM) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
2980 BEVERLY GLEN CIRCLE LOS ANGELES, CA 90077 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 83 | 21 | 21 | 223 | 12 | 41 | 25 | ||
| Cash and cash equivalents | 83 | 21 | 21 | 223 | 12 | 41 | 25 | ||
| Receivables | 328 | 273 | 182 | 159 | 203 | 238 | 397 | ||
| Inventory, net of allowances, customer advances and progress billings | 92 | 124 | 125 | 85 | 127 | 279 | 384 | ||
| Inventory | 92 | 124 | 125 | 85 | 127 | 279 | 384 | ||
| Prepaid expense | 302 | 544 | |||||||
| Other current assets | 330 | 243 | 229 | 430 | 192 | 298 | 308 | ||
| Total current assets: | 833 | 660 | 557 | 898 | 534 | 1,157 | 1,658 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 54 | 68 | 79 | 91 | 107 | 139 | 171 | ||
| Intangible assets, net (including goodwill) | 1,540 | 1,721 | 1,762 | 1,811 | 1,859 | 1,925 | 1,993 | ||
| Intangible assets, net (excluding goodwill) | 1,540 | 1,721 | 1,762 | 1,811 | 1,859 | 1,925 | 1,993 | ||
| Total noncurrent assets: | 1,594 | 1,789 | 1,841 | 1,903 | 1,966 | 2,064 | 2,164 | ||
| TOTAL ASSETS: | 2,427 | 2,449 | 2,398 | 2,800 | 2,500 | 3,221 | 3,821 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,050 | 10,296 | 9,196 | 12,404 | 12,731 | 11,420 | 10,928 | ||
| Taxes payable | 736 | ||||||||
| Employee-related liabilities | 3,475 | 3,997 | 3,468 | 3,208 | |||||
| Accounts payable | 1,864 | 1,982 | 1,926 | 2,114 | 1,460 | 1,384 | 1,379 | ||
| Accrued liabilities | 8,186 | 7,578 | 7,271 | 6,815 | 7,274 | 6,568 | 6,342 | ||
| Debt | 2,119 | 1,902 | 1,475 | 1,757 | 1,093 | 993 | 1,615 | ||
| Derivative instruments and hedges, liabilities | 1 | 1 | 46 | 137 | 18 | 68 | 31 | ||
| Due to related parties | 2,504 | 2,504 | 2,504 | 2,504 | 2,504 | 2,519 | |||
| Other undisclosed current liabilities | (736) | (3,475) | (3,997) | (3,468) | (818) | ||||
| Total current liabilities: | 14,675 | 13,968 | 13,221 | 13,328 | 12,350 | 11,533 | 11,756 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 104 | 258 | 741 | 562 | 122 | 396 | |||
| Long-term debt, excluding current maturities | 104 | 258 | 741 | 562 | 122 | 396 | |||
| Liabilities, other than long-term debt | 567 | 557 | 547 | 531 | |||||
| Due to related parties | 567 | 557 | 547 | 531 | |||||
| Total noncurrent liabilities: | 671 | 815 | 1,289 | 1,093 | 122 | 396 | |||
| Total liabilities: | 15,346 | 14,783 | 14,510 | 14,421 | 12,472 | 11,929 | 11,756 | ||
| Equity | |||||||||
| Equity, attributable to parent | (12,895) | (12,334) | (12,112) | (11,620) | (9,972) | (8,708) | (7,935) | ||
| Common stock | 28 | 28 | 27 | 27 | 27 | 27 | 26 | ||
| Additional paid in capital | 17,038 | 17,018 | 17,002 | 16,949 | 16,919 | 16,699 | 16,459 | ||
| Accumulated deficit | (29,961) | (29,380) | (29,142) | (28,596) | (26,917) | (25,434) | (24,420) | ||
| Equity, attributable to noncontrolling interest | (23) | ||||||||
| Total equity: | (12,919) | (12,334) | (12,112) | (11,620) | (9,972) | (8,708) | (7,935) | ||
| TOTAL LIABILITIES AND EQUITY: | 2,427 | 2,449 | 2,398 | 2,800 | 2,500 | 3,221 | 3,821 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 1,289 | 1,562 | 1,342 | 1,068 | 1,416 | 1,674 | 2,221 | |
| Cost of revenue (Cost of Goods and Services Sold) | (513) | (497) | (535) | (551) | (651) | (496) | (510) | |
| Gross profit: | 776 | 1,065 | 807 | 517 | 765 | 1,178 | 1,711 | |
| Operating expenses | (1,143) | (1,082) | (1,179) | (1,792) | (1,881) | (1,866) | (1,807) | |
| Operating loss: | (367) | (17) | (371) | (1,275) | (1,116) | (688) | (96) | |
| Nonoperating expense | (238) | (221) | (175) | (404) | (367) | (326) | (261) | |
| Interest and debt expense | 238 | 265 | (288) | (264) | ||||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (238) | (265) | 288 | 264 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (605) | (238) | (546) | (1,678) | (1,483) | (1,014) | (357) | |
| Income from equity method investments | 12 | |||||||
| Other undisclosed income from continuing operations before income taxes | 734 | |||||||
| Loss from continuing operations before income taxes: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (357) | |
| Income tax expense | (66) | |||||||
| Loss from continuing operations: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
| Loss before gain (loss) on sale of properties: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
| Net loss: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
| Other undisclosed net income (loss) attributable to parent | 23 | (12) | (734) | |||||
| Net loss available to common stockholders, diluted: | (581) | (238) | (546) | (1,678) | (1,483) | (1,014) | (423) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
| Comprehensive loss: | (605) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 23 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (581) | (238) | (546) | (1,666) | (749) | (1,014) | (423) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.